NeuRA
Off the back of US approval of Leqembi, we have expert Dr Bill Brooks available to discuss Alzheimer's disease.
Dr Brooks has studied Alzheimer's Disease throughout his career and can comment on how the drug aims to work, what the evidence so far shows and also generally about Alzehimer's disease and its progression.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
